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Summary 
Mice homozygous for a 32-microglobulin (32-m) gene disruption lack 32-m protein and are 
deficient for functional major histocompatibility complex class I (MHC-I) molecules. The mutant 
mice have normal numbers of CD4+8 -  T  helper cells,  but  lack MHC-I-directed CD4-8 + 
cytotoxic T  lymphocytes (CTLs).  In this study we used the 3~-m mutant mice to study the 
importance of MHC-I-directed immunity in skin graft rejection. Our results indicate that MHC- 
I-directed CD8 + CTLs  are not essential in the rejection of allografts with whole MHC  or 
multiple minor H  differences. However, the absence of MHC-I-guided immunity profoundly 
reduces the ability of mutant mice to reject H-Y disparate grafts.  In addition,  we show that 
natural killer cells which vigorously reject MHC-I-deficient bone marrow grafts, are not effective 
in the destruction of MHC-I-deficient skin grafts. 
S 
everal crucial aspects of murine skin graft rejection remain 
unclear. One controversy concerns the cell surface marker 
expression and functional properties of the T  cell popula- 
tions effective in mediating graft rejection. Depending on 
the experimental model and the nature of the graft, a crucial 
role has been suggested for lymphokine-producing Th cells 
(1-3),  CTLs, reference 4-7,  or for a functional interaction 
between Th and CTLs (8-12).  In addition, critical biolog- 
ical significance has been suggested for so called dual func- 
tion T  cells, namely Th cells with cytolytic function or Ib 
2-producing CTLs (13). Another, related issue is the relative 
importance of recognition of MHC-P versus  -II molecules 
by the effector T  cells. Under normal circumstances, most 
cells in the skin only express MHC-I molecules. However, 
it has been documented that certain lymphokines e.g., IFN-3', 
that are most likely produced by many antigen-stimulated 
Th host cells during skin graft rejection readily induce MHC-II 
expression on a number of defined cell types in vivo, including 
endothelia and keratinocytes (14-16).  Finally,  the presence 
and  migration  of highly  immunogenic,  MHC-II +  "pas- 
senger" dendritic cells in the skin graft, may be of critical 
1 Abbreviations used in this paper: /~2-m, /32-microglobulin; CML, cell- 
mediated  lymphocytotoxicity;  MHC-I, major histocompatibility  complex 
class I; MHC-II, major histocompatibility  complex  class II; MST, mean 
survival time; NMS, normal  mouse serum; poly I.C., polyinosinic:poly- 
cytidylic acid. 
importance (17, 18), but controversy exists over whether these 
cells express  MHC-I (19,  20). 
Recently, we described the main characteristics of mutant 
mice homozygous for a fl2-microglobulin (~2-m) gene dis- 
ruption that were generated by homologous recombination 
in  embryonic stem cells  (21,  22).  The  mutant  mice lack 
B2-m protein  and consequently express little if any func- 
tional MHC-I cell surface molecules (22). The mutant mice 
contain normal numbers of 3r//~ T cells and MHC-II-guided 
ot/~ TCR + CD4+8 -  ceils, but are deficient for cr  TCR + 
CD4-8 +  CTLs,  because they lack expression of MHC-I 
molecules crucial for positive selection of CD8 + CTLs in 
the thymus (22-25).  Therefore, these mice lack both the 
MHC-I-directed  CTLs,  as  well  as  the  MHC-I  restric- 
tion/target  element.  Radioresistant  NK  cells  present  in 
MHC-I + recipients vigorously reject bone marrow grafts 
from MHC-matched B2-m  mutant  donors  (26,  27).  The 
mutant mice themselves are deficient for this NK cell activity, 
indicating that MHC-I molecules may be involved in the posi- 
tive selection or tolerance induction of NK cells (26,  27). 
In the present study, we used the mutant mice to study the 
importance of MHC-I-guided T and NK cells in murine skin 
graft rejection. 
Materials and Methods 
Mice.  Chimeric animals transmitting the disrupted/~2-m gene 
(21) of the D3 embryonic stem cell line (129/Sv strain-derived, 
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mutant  offspring were back-crossed  three times with wild-type 
129/Sv mice. Subsequently, heterozygous 129 mice were interbred 
to obtain heterozygous (+/-)  and homozygous mutant  (-/-) 
129/Sv mice. In addition, (129/Sv  x  C57BL/6)F1  +/-  animals 
were back-crossed  three times with C57BL/6 (H-2  b) and subse- 
quently interbred to obtain mutant mice on a C57BL/6 background. 
Furthermore, (129/Sv  x  C57BL/6)F1 mice were also back-crossed 
four times with B10.BR (H-2  k/k) mice and thereafter intercrossed 
to obtain heterozygous and mutant (H-2  k/k) mice. 
The ~2-m genotype was determined by Southern blot analyses 
on tail DNA as described (21). B10.BR back-cross mice were selected 
for a H-2  k/k genotype by PCR screening for the absence of the 
Ab  k gene and the presence of the Ea  k gene. The primers were 5'- 
cttccccaggggagtctccacatt-3' (first intron) and 5'-cagcccaccacccag- 
ttctccaga-Y (third exon) for the Ab  b gene and 5'-cctagcaacaggat- 
gggtgtcagtct-Y (first exon) and 5'-ctcaactaagtctgagtcatttt-Y (second 
intron) for the Ea  b gene. 
Skin Grafting.  Skin grafting was performed according to the 
method of Billingham and Medawar (28). Full-thickness skin (~1.5 
cm in diameter) from the back or belly of a donor mouse (6-12- 
wk-old) was engrafted onto the right side of the thorax of a recip- 
ient mouse (2-4-mo-old). The graft was covered with gauze and 
plaster that were removed on day 9. Grafts were scored daily until 
rejection (defined as >80% of the grafted tissue),  or until 120 d 
after transplantation. 
H-Y  Immunization.  Female  mice  were  primed  by  one  in- 
traperitoneal injection of 2,000 rad-irradiated  5  x  107 male spleen 
cells in 0.5 ml PBS, 4-5 wk before the in vitro generation of CTLs. 
In Vitro Generation of  H-Y or Allo-specific CTL.  CTLs were gener- 
ated with minor modifications as described (29).  10  s spleen cells 
from naive or in vivo primed mice (3-5 wk after rejection of a 
skin graft) were cultured with 2,000 tad-irradiated  stimulator spleen 
cells (10  s) in 80 ml culture medium for 5 d at 37~  in humidified 
air with 5% CO2. The culture medium consisted of RPMI 1640 
supplemented with 10%  FCS,  antibiotics and 2-ME (2  x  10 -s 
M).  After  5  d  in  culture,  viable  cells  were  purified  using  a 
Lympholyte-M gradient (Cedarlane Labs., Ltd., Westbury, NY). 
Cell-mediated Lymphocytotixicity.  Varying numbers of effectors 
cells were added to 5  x  103 Na2SlCrO4 (SlCr)-labeled target cells 
in 0.2-ml culture medium in 96-well round-bottomed microtiter 
plates and incubated for 4 h at 37~  in humidified air with 5% 
CO2, as described (29).  Con A (0.7 #g/ml) or LPS (25 #g/ml)- 
induced lymphoblasts, the EL-4 (H-2  b) and YAC-1 (H-2  ~) T  cell 
lines, the P815 mastocytoma cell line (H-2d), the Rl.l(H-2k), and 
RIE.TL8.XI(H-2  k, B2-m-deficient variant, 30, 31) thymoma cell 
lines were used as targets. ED4 is derived from a benzl:9"rene-induced 
T cell tumor of C57BL/6 mouse strain origin. YAC-1 is a T cell 
lymphoma induced by Moloney MuLV in the A/Sn strain. P815 
cells are derived from a mastocytoma induced by benzpyrene in 
the DBA/2 strain.  K1.1 cells were derived from a thymoma ofC58 
strain origin. 
In the allo-specific CML, lysis was performed in RPMI  1640 
supplemented with 10% FCS. In the H-Y-specific CML, the lysis 
was performed in AIM V ~ (serum-flee lymphocyte) medium (Gibco 
Laboratories,  Grand Island,  NY). After incubation, the superna- 
tant was collected with the Titertek Supernatant Collection system 
(Skatron Inc., Sterling, VA). The levels of cytotoxicity  are expressed 
as percent specific S~Cr-release in a 4-h assay (29). 
SV4O Large T lmmortalized Fibroblasts.  14-d-oldembryonic 129 
mouse strain fibroblasts were grown for 3 d in DMEM supplemented 
with 10%  FCS,  antibiotics, and t-glutamine (regular medium). 
Subsequently, cells were infected with a helper virus-flee, cell-free 
supernatant of the ~2 SV40-6 cells, containing a replication-defective 
recombinant retrovirus expressing the SV40 large T  gene as de- 
scribed (32). Infected cells were selected by culture under low serum 
concentration (1%) for 2 wk. Uninfected control cultures rapidly 
died under these conditions. After selection,  bulk cultures of in- 
fected, immortalized cells were maintained in regular medium. Be- 
fore the NK cell assay, cells were washed twice with Hepes, and 
the cells were detached with Hepes  supplemented with  1-mM 
EDTA. Thereafter, cells were washed in excess regular medium and 
labeled  with SlCr, as described in the previous section. 
NK Cell Assay.  Single cell suspensions were obtained from the 
spleens of 6-12-wk-old (129  x  C57BL/6)FI  +/-  mice injected 
intraperitoneally 24 h before with 150 #g polyinosinic:polycyti- 
dylic acid (poly I.C.) in PBS, as described (33). Erythrocytes were 
lysed by treatment with an isotonic NH4CI solution (29),  and 
thereafter the majority of macrophages and B cells removed by in- 
cubation on 16-cm tissue culture dishes for 1.5 h at 37~  as de- 
scribed (34). Varying numbers of the nonadherent effector cells and 
5  x  103 SlCrO4-1abeled target cells were incubated for 5 h at 37~ 
in 0.2 ml of RPMI 1640 supplemented with 10% FCS, antibiotics, 
r-glutamine,  and 2-ME (2  x  10 -s M). 
Depletion  of Effector Cell  Populations.  Viable  effector  cells 
(107/ml) were incubated for 1 h at 37~  with no antibody, NMS 
(1:100 dilution), anti-CD4 mAb (50% culture supernatant of hy- 
bridoma RL.172, [35]), anti-CDScx mAb (9YTS 169.4, 1:100 dilu- 
tion of ascites fluid, [36]), or anti-NKl.1 mAb (PK 136, 1:100 di- 
lution of ascites fluid, [37]) plus complement (1:10 low Tox-M rabbit 
complement,  Cedarlane  Labs.,  Ltd.).  Subsequently,  cells  were 
washed with excess medium and the surviving cells were tested 
for cytolytic activity. No difference was observed in the cytolytic 
activity of cells nontreated or treated with NMS (1:100) and com- 
plement (data not shown). Effector cell numbers were not adjusted 
for the number of cells killed  by the mAb plus C  treatment. 
Immunofluorescence Staining Analysis.  Viable effector cells were 
washed in flow cytometry buffer (PBS containing 0.5% BSA and 
0.01% NAN3), and 5  x  10  s cells were incubated with mAb in a 
volume of 25/A. The following mAbs were used: PE-conjugated 
anti-CD4 (GK.1.5, Becton Dickinson & Co., Mountain View, CA 
[38]), FITC-conjugated anti-CDSc~ (53-6.7,  Becton Dickinson & 
Co., [39]), biotin-labeled anti-TCR ce/~/(H57-597, [40]), FITC- 
labeled anti-CD3 (45-2Cll, [41]), and control rat Ig2b FITC-labeled 
(Pharmingen, San Diego, CA). To stain cells with bound biotin- 
labeled antibodies, cells were washed and thereafter incubated with 
PE-streptavidin (Becton Dickinson & Co.). Cells (104) were ana- 
lyzed on an Epics C (Coulter Corp. Cytometry, Hialeah, FL) in 
a two-color mode. Dead cells were excluded based on forward and 
90~  light scatter characteristics. 
Results 
~e-m  Mutant  Mice  Rapidly  Reject  Whole  MHC-disparate 
MHC Class I + Skin Grafts.  To evaluate the importance of 
MHC-I-directed immunity,  we used ~2-m mutant  mice as 
donors and as recipients for engraftment of whole MHC and 
minor H  antigens mismatched skin grafts. Normal BALB/c 
(H-2  d) mice readily rejected both  -/-  and  +/-  129 (H-2  b) 
grafts with similar survival times (Table 1). In addition, both 
(129  x  C57BL/6)F3  -/-  and  +/-  (H-2  b) mice rapidly re- 
jected wild-type BALB/c (H-2  a) grafts.  Furthermore, both 
129 (H-2  b)  -/-  mutant and  +/-  control mice rapidly re- 
jected  skin  grafts  from  normal  B10.BR  (H-2  k)  donors 
(Table 1). 
886  Relevance  of MHC Class I Antigens in Murine Skin Graft Rejection Table  1.  Rejection  of reliC Disparate Grafts by Wild-Type and ~2-m Mutant Mice 
Donor  Host* 
MST 
Strain  H-2  32-m*  Strain  H-2  32-m  (mean _+  SD)  Fraction rejecting 
129  b 
129  b 
BALB/c  d 
BALB/c  d 
B10.BR  k 
B10.BR  k 
129  b 
129s  b 
+  m 
+  + 
+  + 
+  + 
+  + 
+  -- 
+  -- 
d 
BALB/c  d  + / +  12.7  +  1.2  4/4 
BALB/c  d  + / +  12.0  +  0.8  5/5 
(129  x  C57BL/6)F3  b  /  9.4  +  1.2  5/5 
(129  x  C57BL/6)F3  b  +/-  10.3  +  0.4  3/3 
129  b  -/-  14.2  +  1.3  5/5 
129  b  +/-  12.6  +  0.4  3/3 
129  b  -/-  13.7  +  2.1  4/4 
129s  b  /  12.1  +  2.1  6/6 
* Male skin was transplanted to male recipients. 
* fl2-m genotype: - / -, homozygous  /~2-m gene mutant; + / -, heterozygous  B2-m mutant; + / +, wild-type. 
S  Females. 
To study the possible effector cells, we tested recipient mice 
after the rejection of the graft, for the presence  of donor- 
specific CTLs. Spleen cells of recipient mice were restimu- 
lated in vitro with irradiated spleen cells of the strain used 
as skin donor. As expected, strong CTL activity was detected 
in cultures derived from naive or primed +/-  recipients (Fig. 
1). No CTL activity was detected in cultures from naive mu- 
tant mice (Fig.  1).  In contrast, two of the five tested (129 
x  C57BL/6)F3  mutant  mice  (H-2b),  that  had  rejected 
BALB/c (H-2  d) grafts, showed weak H-2d-specific CTL ac- 
tivity, and in the other three cultures no CTL activity was 
seen (data not shown). When mutant 129 (H-2  b) mice that 
had rejected B10.BR (H-2  k) skin were tested,  two of the 
four animals showed weak H-2k-specific CTL responses (Fig. 
1).  The weak CTL activity was specific for MHC-I mole- 
cules of H-2  k because  MHC-II-  R1.1  (H-2  k) T  cells were 
lysed, whereas EL-4 (H-2  b) and the variant R1E.TL- (H-2  k) 
target cells, which lack 32-m protein synthesis and conse- 
quently MHC-I cell surface expression (30, 31), were not lysed 
(data not shown). The weak CTL activity was mediated by 
CD4-8 + cells because depletion of the effector cells by anti- 
CD4 mAb plus C had no effect (data not shown), but treat- 
ment with anti-CD8 mAb plus C eliminated the lysis of the 
R1.1  (H-2  k) target cells (Fig.  1).  Flow cytometric analysis 
of the effector cells confirmed the presence of a low number 
of CD3 +, TCR-od3 + CD4-8 + cells (1-3%) in the mutant 
effector cells. In contrast, in the effector cells of naive mutant 
mice and of the two nonresponding primed mutant mice, 
no CD4-8 + cells were detected (data not shown). We con- 
clude that the rejection of fully allogeneic skin grafts by mu- 
tant mice is accompanied by the generation of a low number 
of MHC-I-directed CD8 + CTL- in some, but not in other 
recipients. 
Mutant Mice Rap@ Reject "Syngeneic" MHC-I  + Grafts. 
It was interesting to examine whether the mutant mice would 
be tolerant for the 32-m protein and syngeneic MHC-class 
I molecules.  For that reason, 129 mutant recipients were en- 
grafted with sex-matched 129 strain +/-  skin. Both female 
and male mutant hosts vigorously rejected these grafts in about 
13 d (Table 1). To examine the role of self MHC-I-specific 
CTLs, we tested restimulated spleen cell cultures of four male 
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Figure 1.  H-2k-specific  CTL responses of 32-m mutant (O) and 32-m 
heterozygous (O)  129 (H-2  b) mice after rejection of a  +/+  B10.BR 
(H-2  k) skin graft. Spleen cells from mice 3-4 wk after the rejection of 
the graft or naive  mice were stimulated  for 5 d with B10.BR spleen cells, 
as described  in Materials  and Methods.  Lysis  by the effector  cells  was mea- 
sured against RI.1 (H-2  k) T cell targets. No significant  lysis was seen 
against 32-m-defident R1E.TL- (H-2  k) variant cells (data not shown). 
Each curve  represents the CTL activity  of an individual  responder  mouse. 
887  Zijlstra  et al. Table  2.  Rejection of Skin Gratis with Multiple Minor H Differences in 1-1-2  k Mice 
Donor  Host* 
Strain  fl2-m*  Strain  fl2-m 
MST 
(mean  _+  SD)  Fraction rejecting 
B10.BK BC  s  donor 1  -  / -  B10.BK  + 
B10.BIL BC  donor 2  -/-  B10.BK  + 
B10.BK BC  donor 3  -/-  B10.BK  + 
B10.BK BC  donor 1  +/-  B10.BK  + 
B10.BK BC  donor 2  +/-  B10.BK  + 
d 
+  16.6  _+  4.2 
+  17.8  _+  2.0 
+  16.3  _+  3.8 
+  17.4  _+  3.6 
+  14.6  _+  2.5 
5/5 
6/6 
3/3 
5/5 
6/6 
* Male skin was grafted onto male recipients. 
t fi2-m genotype (see Table 1 legend). 
$ Derived from (129  x  C57BL/6)F1 mice back-crossed four generations onto a B10.BR (H-2  k) background. 
recipients  for  the  presence  of CD8 §  CTLs  reactive  with 
Eb4 (H-2  b) target cells. Only one responder showed CD8 + 
CTL activity, and in the other three effector cell populations, 
no CTL activity was seen (data not shown). Therefore, the 
generation of H-2b-reactive CTLs is not essential for the re- 
jection of syngeneic MHC-I + positive grafts. 
Mutant Mice Readily Reject Skin Gratis with Multiple Minor 
H  Differences.  To study the importance of MHC-I in the 
rejection of skin grafts with multiple minor H  differences, 
we performed  skin  grafting in both  H-2  b and  H-2  k mice. 
Mutant  and  +/-  control skin derived from mice (H-2  k/k) 
back-crossed four generations onto a B10.BR background, 
were transplanted onto wild-type B10.BK (H-2  k) mice. As 
can be seen in Table 2, both mutant and control grafts were 
readily rejected, with similar mean survival times of the skin 
grafts. 
Similarly, Table 3 shows that wild-type +/+  C57B1/6 mice 
readily rejected both mutant and +/-  skin 129 strain grafts 
(H-2 b, multiple minor H  differences). It seems possible that 
cells of the 129 mutant skin graft absorbed some B2-m pro- 
tein from the C57BL/6 host, thereby acquiring some MHC-I 
surface expression and susceptibility to MHC-I-guided im- 
munity (26, 42). To address this issue, we also grafted mu- 
tant skin onto mutant hosts with multiple minor H  differ- 
ences. In both directions, grafts were rapidly rejected by both 
mutant and control littermates after a similar latency (Table 
3).  These results indicate that in skin grafts with multiple 
minor H  differences,  the expression of MHC-I and MHC- 
I-guided CTLs  are not essential  for graft rejection. 
MHC-1  Expression Profoundly Influences Rejection of H-Y- 
Disparate Gratis.  A  vast  majority  of  female  H-2  b  mice 
readily reject H-Y disparate skin grafts which is generally ac- 
companied by the generation of strong MHC-I-restricted 
H-Y-specific CTLs (43-45).  We therefore examined inbred 
Table  3.  Rejection of Skin Gratis with Multiple Minor H Differences in 1-1-2  ~ Mice 
Donor  Host* 
Strain  B2-mt  Strain  /~2-m 
MST 
(mean  _+  SD)  Fraction rejecting 
129  -/-  (129  x  C57BL/6)F1  +/- 
129  -  / -  C57BL/6  + / + 
129  + / -  C57BL/6  + / + 
129  -  / -  C57BL/6 BC  s  / 
129  -  / -  C57BL/6BC  + / - 
C57BL/6 BC  -  / -  129  / 
C57BL/6 BC  -  / -  129  + / - 
d 
>120 
14.0  _+  1.0 
12.5  _+  0.8 
13.0  _+  0.8 
13.0  _+  1.2 
13.4  _+  0.4 
13.3  _+  0.4 
0/6 
8/8 
8/8 
3/3 
4/4 
5/5 
3/3 
* Male skin was grafted onto male recipients. 
* fi2-m genotype (see Table 1 legend). 
S Derived from (129  x  C57BL/6)F1 mice back-crossed three generations onto a C57BL/6 background. 
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Figure 2.  Survival  of H-Y disparate skin gratis in inbred mutant and 
heterozygous control 129 (H-2  b) mice. +/-  females (F) were engrafted 
with +/- male(M)(n = 8), and -/- F engrafted  with -/- M (n = 11). 
129 (H-2  b) mutant  and  +/-  control females for the rejec- 
tion of male skin grafts.  Control  +/-  females rapidly re- 
jected male  +/-  grafts with a mean survival time of about 
18 d (Fig.  2). In contrast,  9 of 11 mutant females accepted 
mutant male skin for at least 120 d (Fig. 2), and two other 
animals  rejected it after a long latency.  In these animals,  a 
small residual graft was accepted, but because it consisted 
of <20%  of the size of the original graft, they were scored 
as rejected. To examine the role of H-Y specific  CTLs,  we 
tested in vivo immunized mutant and  +/-  animals for the 
in vitro generation of H-Y-specific CTLs. To exclude the pos- 
sible absorption by the target cells of 32-m protein derived 
from the FCS in the regular culture medium, we performed 
the CML in serum-free medium. As expected, all four tested 
immunized  +/-  females, mounted strong H-Y-specific CTLs 
(Fig.  3).  The CTLs possessed a CD4-8 + phenotype (data 
not shown).  These H-Y-specific CTLs did not lyse mutant 
male target cells (Fig.  3). This result implies that in the ab- 
sence of exogenous  flu-m  protein,  the  MHC-I  molecules 
cannot present H-Y antigen-derived peptides.  Consistent with 
this conclusion, we could not detect any CTL activity, in- 
cluding H-Y specific, in cultures derived from four tested im- 
munized mutant females (Fig. 3). In the latter experiment, 
no lysis was observed of con A-stimulated T cell blasts (Fig. 
3), nor LPS-stimulated mutant male B cell blasts (data not 
shown).  We therefore conclude that  32-m mutant  females 
do not generate MHC-I-guided H-Y specific CTLs and that 
this  is  not  compensated  for  by  MHC-II-restricted  H-Y 
specific  CTLs. 
MHC-I +  Recipients  Fail  to  Reject  MHC-I-defieient  Skin 
Grafts.  Previous  studies  have  shown  that  radioresistant 
NKI.1 + NK cells present in MHC-I + recipients vigorously 
reject haemopoietic grafts from MHC-matched 32-m  -/- 
donors (26, 27).  NK cell-mediated rejection of skin grafts 
would severely complicate the interpretation of many of the 
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Figure 3.  H-Y-specific  CTL responses of an immunized •2-m  mutant 
(0) and an immunized heterozygous (O)  129 (H-2  b) female. Similar 
results were obtained with three other primed mutant and three +/- 
females (data not shown). Mutant females were immunized with mutant 
male cells and heterozygous females were immunized with heterozygous 
male cells as described in Materials and Methods. Spleen cells were re- 
stimulated in vitro with similar cells used  for immunization. Effector  ceils 
were tested against con A-stimulated 129 mouse strain T cell blasts of in- 
dicated sex and ~2-m genotype. The CML was performed in AIMV 
serum-free medium. 
above described experiments. In addition, we wanted to com- 
pare the biology of the NK cells rejecting MHC-deficient 
bone  marrow  grafts  (26,  27)  with  those  displaying  the 
phenomenon of "hybrid resistance" In the latter situation, 
irradiated MHC-heterozygous mice often reject haemopoietic 
ceils from one of the homozygous parental  strain,  but do 
accept  nonlymphoid  parental  grafts,  including  skin  grafts 
(46-49). To assess the possible role of NK cells in skin graft 
rejection,  we performed  skin grafting  in similar combina- 
tions that lead to rejection of mutant bone marrow grafts, 
namely skin from 129  -/-  donors to 129  +/-  and (129 
x  C57BL/6)F1  +/-  (H-2  b) recipients.  As can be seen in 
Table 4, all +/-  hosts accepted the mutant graft over a period 
of at least 120 d. Therefore, NK cells are not effective in the 
rejection of MHC-I-deficient  skin  transplants. 
Mutant  Fibroblasts  Are Not  Highly  Susceptible  to Lysis  by 
NKI.I § NK Cells.  To study the difference between the re- 
jection of mutant  bone marrow  grafts  (26,  27) versus the 
acceptance of mutant skin grafts by +/-  hosts (this study), 
we compared lymphoid and nonlymphoid mutant target cells 
with respect to NK ceU-mediated lysis. As a source of non- 
lymphoid cells, we used immortalized, embryonic fibroblasts. 
No difference was seen in the level of NK cell mediated lysis 
of -/-  and +/-  fibroblasts (Fig. 4). Most effector cells did 
not express the NKI.1  cell marker because depletion with 
889  Zijlstra et al. Table  4.  MHC  Class I + Mice Fail to Reject firm Mutant Skin  Grafts 
Donor  Host* 
Strain  ~2-m*  Strain  B2-m  n  Antigenic Disparity  Survival time 
129  s  + /  -  129  + 
129  +/-  (129  x  C57BL/6)F1  + 
129  /  129  + 
129  /  (129  x  C57BL/6)F1  + 
d 
-  14  None  >120 
-  6  None  >120 
-  7  ~2-m  >120 
-  6  Bz-m  >120 
* Male skin grafts were transplanted  onto male recipients, except for the top group which included seven female grafts engrafted into female recipients. 
* B2-m genotype (see Table 1 legend). 
S Both 129 and (129  x  C57BL/6)F1  mice are of H-2  b type. 
anti-NKl.1 mAb plus C only marginally affected target cell 
lysis. This is in contrast with the results obtained with  -/- 
and  +/-  Con A-stimulated T cell blasts (Fig.  4 and refer- 
ence 27).  The NK cells efficiently lysed  -/-  targets, but 
did not lyse +/-  targets. A similar difference was seen when 
Genotype Target Cells 
r  >. 
_J 
_o 
U. 
5 
I,U 
n 
U) 
-/-  MUTANT  +/- CONTROL 
40 
20 
40 
20 
/ 
NKI.1- 
O  O  O  a  8 
!  I  I  I  I  I 
10  30  90  10  30  90 
Target 
Cell 
Type 
T cell 
blasts 
Flbro- 
blasts 
EFFECTOR / TARGET  RATIO 
Figure 4.  NK cell-mediated lysis of mutant and  +/-  T cell blasts and 
embryonic fibroblasts. T cell blasts were obtained from Con A-stimulated 
spleen cells from (129  ￿  C57BL/6)F3 mice. 129 mice derived, SV40 large 
T immortalized cultures of embryonic fibroblasts were obtained as described 
in Materials and Methods.  Poly l.C.-stimulated spleen cells from (129  x 
C57BL/6)Ft  +/-  mice were used as source of NK cells. No significant 
lysis was observed when unstimulated  spleen cells were used as effector 
cells (data not shown).  Enrichment of the NK cells and depletion of the 
effector cells by anti-NK-l.1 mAb plus C  is described in Materials  and 
Methods.  Effector cells were treated  with NMS plus C  (O), or treated 
with anti-NKl.1 mAb plus C  (O). 
-/-  and +/-  LPS-stimulated B cell blasts were compared 
(data not shown). Furthermore, anti-NKl.1 mAb plus C treat- 
ment of the effector cells completely abolished the lysis of 
the -/-  con A targets (Fig. 4 and reference 27). We there- 
fore conclude that the difference in fate between mutant bone 
marrow (rejected) versus  skin (accepted) after engraftment 
into  +/-  hosts, can be explained by a difference in suscepti- 
bility to NKI.1 + NK cells between lymphoid (susceptible) 
and nonlymphoid (resistant) mutant cells. 
Discussion 
The central issue addressed in this study is the need for 
MHC-I-directed immunity in skin graft rejection, using mu- 
tant mice that have normal subsets of TCR-ot/B + CD4+8 - 
Th cells and 3'/~ T  cells, but that are deficient for mature 
CD4-8 + CTLs  (22-24).  The results suggest that MHC- 
I-directed CTLs are not essential in the rejection of strong 
antigenic grafts, such as whole MHC disparate grafts or grafts 
with multiple minor H differences. In contrast, our experi- 
ments indicate that MHC-I-guided immunity is pivotal in 
the rejection of H-Y disparate grafts. 
After the engraftment of whole MHC disparate skin grafts, 
a low number of graft-specific CD8 + CTLs were detected 
in some of the recipient mutant mice, but no CTL activity 
or  CD8 +  T  cells  were  seen  in  other  recipients.  Similar 
results were obtained with mutant mice grafted with syn- 
geneic MHC-I + grafts. No difference was seen in the sur- 
vival time of the skin grafts in mice with or without CTL 
activity. In our view, this suggests that rejection of these grafts 
by the mutant mice is not dependent on MHC-I-directed 
CTL.  The mechanism leading to the partial rescue of the 
mutant phenotype is not dear. One possibility is that/~2-m 
protein secreted by the skin graft or skin graft-derived lym- 
phocytes, migrates to the thymus and, temporarily, partially 
restores the MHC-I-dependent process of positive selection 
of CD8 + CTLs.  Otherwise,  direct induction of thymus- 
independent CD8 + CTLs (50) by cells in the skin graft may 
occur. Mutant and control skin were both rapidly rejected 
by aUogeneic wild-type hosts. In the presence of FCS-derived, 
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cells for allo-specific CTLs, although about ninefold less sus- 
ceptible than wild-type cells (22). This could be still sufficient 
for rapid skin graft destruction. Alternatively, our results are 
in concordance with studies showing that purified CD4 +8- 
T cells are able to reject fully allogeneic skin grafts (1-3, 11). 
After the engraftment of skin with multiple minor H differ- 
ences, no differences were seen in the survival of mutant versus 
control grafts. Furthermore, reciprocal grafts between mu- 
tant mice with multiple minor H  differences were rapidly 
rejected.  This  indicates  that  a  strong Th  cell response is 
sufficient for skin graft rejection. This conclusion is consis- 
tent with reported studies suggesting that purified CD4 +  8- 
T cells can mediate rejection of skin grafts with multiple minor 
H  differences (9,  11). 
The ~2-m mutation has a profound impact on the ability 
of the mutant mice to reject H-Y disparate skin grafts. This 
strongly argues that in normal 129  mice, MHC-I-guided 
CTLs have a pivotal role in the destruction of H-Y disparate 
grafts. The same conclusion was made in studies showing 
that both Th and CTLs are required for the rejection of H-Y 
disparate grafts (11, 45).  Wild-type H-Y-specific CTLs fail 
to lyse mutant male target cells and no H-Y-specific CTLs 
could be demonstrated in the mutant mice. These observa- 
tions indicate that in the absence of endogenous/32-m pro- 
tein, the MHC-I molecules cannot present H-Y antigen-de- 
rived peptides. Because the mutant mice are deficient for both 
the MHC-I-guided CTLs (22, 24), as well as in the presen- 
tation of peptides by MHC-I, no H-Y-specific MHC-I-guided 
CTLs can be generated by the mutant mice. The failure to 
reject male grafts can be explained in several ways. It could 
be that H-Y-specific graft destruction can be mediated exclu- 
sively by CD8 + MHC-I-guided CTLs.  Alternatively, one 
might argue that Th cells do have the potential to mediate 
H-Y-specific graft rejection, but due to the weakness of the 
primary H-Y-specific Th cell response, no graft destruction 
occurs in the recipients. Yet perhaps, the strength of the MHC- 
II-restricted CD4 + T  cell response may not be crucial, but 
an  essential component  thereof,  such as  MHC-II-guided 
CTLs. Indeed, we could not detect any MHC-II-restricted 
H-Y-specific CTL activity in immunized mutant mice. 
Our experiments indicate no significant role for allogeneic 
MHC-I-specific NK cells in skin graft rejection. This strongly 
contrasts with the finding that hemopoietic grafts from mu- 
tant mice are vigorously rejected by radioresistant NKI.1 + 
NK cells present in normal MHC-matched recipients (26, 
27). Our present study dearly demonstrates that this subset 
of NK cells is not effective in the rejection of mutant skin 
grafts. The rejection of mutant haemopoietic cells is consis- 
tent with the high susceptibility of mutant T and B cell blasts 
to  NKI.1 +  NK  cell-mediated lysis.  In  contrast,  mutant 
fibroblasts seem to be refractory to lysis mediated by these 
NK cells. Our findings are in concordance with many studies 
involving MHC-I-  tumor cells, in which an inverse corre- 
lation  is  often seen between MHC-I  expression and  NK 
cell-mediated lysis (for review see reference 48).  However, 
in these studies a considerable number of exceptions have been 
reported, notably in the group of nonlymphoid tumors (48). 
Our results therefore suggest that flz-m mutant fibroblasts 
may either lack the target antigen(s) recognized by NK cells, 
or may be devoid of some cell adhesion molecules crucial for 
NK-target cell interactions. Our skin graft experiment sug- 
gests that this may also be true for many cells in a mutant 
skin graft. 
In summary, our experiments allow three main conclu- 
sions.  First,  NK  cells  highly efficient in  the rejection of 
MHC-I-  bone marrow grafts, are not effective in skin graft 
rejection. Second, CD8 + CTLs are not essential in the re- 
jection of strong antigenic skin grafts. This conclusion im- 
plies that MHC-II-guided T cells are sufficient to induce graft 
rejection, possibly by the generation of lymphokine-induced 
microvascular lesions,  or direct lysis by MHC-II-directed 
CTLs. Finally, in grafts with a limited number of antigenic 
differences, e.g., the H-Y antigen, graft-specific CTLs may 
be pivotal for graft destruction. To explain the need for MHC- 
I-guided CTLs, we favor the hypothesis that the primary 
H-Y-specific Th cell response is too weak or limited in func- 
tional scope to induce graft rejection. This hypothesis predicts 
that immunized mutant mice will reject H-Y disparate grafts 
due to a boosted Th cell response, in the absence of any MHC- 
I-guided CTLs. This experiment and the adoptive transfer 
of H-Y-specific Th clones seems to be well suited to dissect 
the potential of distinct subsets of CD4 § T  cells in murine 
skin graft rejection. 
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